Gavin Corcoran Insider Trading
Get free email notifications about insider trading for Gavin Corcoran.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gavin Corcoran. Gavin Corcoran is a Chief R&D Officer in Axovant Gene Therapies Ltd. ($AXON) and a EVP of R&D in Axovant Sciences Ltd. ($AXON).
Address: C/O AXOVANT SCIENCES, INC. 11 TIMES SQUARE, 33RD FLOOR NEW YORK 10036 NY
Companies in which Gavin Corcoran is an Insider
Sio Gene Therapies Inc.
Trading Symbol: AXONIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gavin Corcoran: Chief R&D Officer, EVP of R&D
Holdings: 25,792 shares
Current Value: $334,522
Latest Transaction: Apr 19 2021
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gavin Corcoran
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | AXON | Sio Gene Therapies ... | Corcoran Gavin | Chief R&D Officer | Option Exercise | A | 2.47 | 244,300 | 603,421 | 244,300 | |
Apr 19 2021 | AXON | Sio Gene Therapies ... | Corcoran Gavin | Chief R&D Officer | Option Exercise | A | 2.47 | 244,300 | 603,421 | 244,300 | |
Mar 19 2021 | AXON | Sio Gene Therapies ... | Corcoran Gavin | Chief R&D Officer | Option Exercise | D | 0.00 | 16,001 | 0 | 0 | |
Mar 19 2021 | AXON | Sio Gene Therapies ... | Corcoran Gavin | Chief R&D Officer | Grant | A | 0.00 | 16,001 | 0 | 25,792 | 9.8 K to 25.8 K (+163.43 %) |
Jun 15 2020 | AXON | Axovant Gene Thera ... | Corcoran Gavin | Chief R&D Officer | Option Exercise | D | 0.00 | 16,002 | 0 | 16,001 | |
Jun 15 2020 | AXON | Axovant Gene Thera ... | Corcoran Gavin | Chief R&D Officer | Payment of Exercise | F | 3.46 | 6,211 | 21,490 | 9,791 | 16 K to 9.8 K (-38.81 %) |
Jun 15 2020 | AXON | Axovant Gene Thera ... | Corcoran Gavin | Chief R&D Officer | Grant | A | 0.00 | 16,002 | 0 | 16,002 | 0 to 16 K |